Schwann cells (SCs) are the myelin producing cells of the peripheral nervous system. During development, SCs cease proliferation and differentiate into either a myelin-forming or non-myelin forming mature phenotype. We are interested in the role of insulin-like growth factor-I (IGF-I) in SC development. We have shown previously SCs proliferate in response to IGF-I in vitro. In the current study, we investigated the role of IGF-I in SC differentiation. SC differentiation was determined by morphological criteria and expression of myelin proteins. Addition of 1 mM 8-bromo cyclic AMP (cAMP) or growth on Matrigel matrix decreased proliferation and induced differentiation of SCs. IGF-I enhanced both cAMP and Matrigel matrix-induced SC differentiation, as assessed by both morphological criteria and myelin gene expression. Cultured SCs also express IGF binding protein-5 (IGFBP-5), which can modulate the actions of IGF-I. We examined the expression of IGFBP-5 during SC differentiation. Both cAMP and Matrigel matrix treatment enhanced IGFBP-5 protein expression and cAMP increased IGFBP-5 gene expression five fold. These findings suggest IGF-I potentiates SC differentiation. The concomitant up-regulation of IGFBP-5 may play a role in targeting IGF-I to SCs and thus increase local IGF-I bioavailability.
Insulin-like growth factor I (IGF-I) can serve as a the myelin-forming cells in the peripheral nervous system. Differentiating, myelin-forming SCs express mydifferentiating factor for a variety of cell types includelin specific proteins, including protein 0 (P0), myelin ing osteoblasts, myoblasts and neuroblasts (Pahlman basic protein (MBP) , myelin-associated glycoprotein et al., 1991; James et al., 1993; Ewton and Florini, (MAG) , and P 2 Trapp et al., 1995; Thrailkill et al., 1995) . The biological effects of 1984) and form a relationship with axons. In vivo, axo-IGF-I are mediated via the type I IGF receptor (IGFnal contact is required for the induction of SC differen-IR) (Jones and Clemmons, 1995; Schmid, 1995) and tiation (Knight et al., 1993 ), yet, the cellular signals modulated by six IGF binding proteins (IGFBP-1 to underlying axonal regulation of SC differentiation and IGFBP-6) (Holly and Martin, 1994; Jones and Clemmyelination are not understood. In vitro, agents which mons, 1995). Expression of IGF-I, IGF-IR and IGFBP elevate intracellular cAMP level, such as forskolin and is tissue and cell-specific and regulated during developcAMP analogues, mimic axonal effects in cultured SCs ment (Bondy et al., 1992; Cerro et al., 1993; Green et to alter SC morphology and activate the expression of al., 1994). IGFBPs transport IGF-I to target tissues myelin proteins including P0 and MBP (Jessen and and modulate IGF-I interactions with IGF-IR in either Morgan et al., 1991) . Similarly, SC differa stimulatory or inhibitory manner (Holly and Martin, entiation requires the presence of a SC basement mem-1994; Jones and Clemmons, 1995) .
brane (Bunge et al., 1989) and, in vitro, SCs undergo IGFBP-5 is the most conserved IGFBP with 97% iden-phenotypic differentiation when grown on substrata of tity between human and rodent homologues (Kou et al., basement membrane components such as Matrigel ma-1994) . IGFBP-5 can associate with cell surface proteins trix (Yoshino et al., 1990) . (Andress, 1995; Jones and Clemmons, 1995) and bind to
We recently reported that IGFBP-5 is expressed in components of the extracellular matrix (Jones et al., 1993; . While IGFBP-5 may have IGF independent effects (Andress and Birnbaum, 1992; Contract Grant sponsor: National Institutes of Health; Contract developing rat SCs (Cheng et al., 1996b) . Additionally, genes and undergoing myelination when cocultured with sensory neurons (Tennekoon et al., 1987 ; Peden after peripheral nerve injury in adult rodents, we found that invading macrophages produce IGF-I and acti-et al., 1990) . In the presence of forskolin, MT4H1 SCs express a similar phenotype to primary SCs. We prevated SCs express both IGF-IR and IGFBP-5 (Cheng et al., 1996a) . In vitro, we discovered that undifferenti-viously reported IGF-I is a mitogen for MT4H1 SCs and demonstrated these cells express both the type I ated SCs express IGF-IR and IGFBP-5 (Cheng et al., 1996a) and that IGF-I protects SC secreted IGFBP-5 IGF receptor and IGFBP-5 (Cheng et al., 1996a) .
MT4H1 cells were maintained in DMEM containing from proteolysis (Cheng et al., 1996a) . These data have led us to speculate that during development or after 10% FBS, 100 mM ZnSO 4 , and 100 mg/ml G418 at 37ЊC in a humidified atmosphere with 10% CO 2 . When injury, Schwann cells secrete IGFBP-5, which may increase local IGF-I bioavailability (Cheng et al., 1996a) . reaching 80% confluency, cells were subcultured with trypsin-ethylenediamine tetraacetic acid (EDTA) into We believe IGF-I, in turn, may enhance Schwann cell differentiation and myelination. In the current study, T75 flasks. In some experiments, cells were grown in defined glial cell medium, designated G3, containing we address these ideas and propose a role for IGF-I and IGFBP-5 in Schwann cell differentiation.
50 mg/ml transferrin, 10 ng/ml biotin, and 30 nM selenium in DMEM (Cheng et al., 1996a) .
MATERIALS AND METHODS
Morphological studies of SC differentiation Dulbecco's modified Eagle medium (DMEM) was purchased from Gibco BRL (Gaithersburg, MD) and fetal Cells were washed twice and plated into Lab-Tek chamber slides (Nunc, Naperville, IL) with DMEM conbovine serum (FBS) from Hyclone (Logan, UT). Other tissue culture supplies were obtained from Corning taining 0.3% FBS at a density of 3 1 10 4 cells/cm 2 in the presence of increasing concentrations of (0, 1, 3, 10 Glass Works (Corning, NY) and Costar (Cambridge, MA). Restriction enzymes were from Gibco BRL and nM) IGF-I in the presence or absence of 1 mM 8-bromo cAMP. In some studies, cells were plated on Growth New England Biolabs (Beverly, MA). 32 P-dCTP was obtained from Amersham (Arlington Heights, IL). Recom-Factor Reduced-Matrigel matrix from Collaborative (Bedford, MA). After 24 hr, the morphology of cells was binant human IGF-I was a generous gift of Cephalon (West Chester, PA) and was stored in 100 mM acetic examined under a phase-contrast microscope. acid in 080ЊC until use. All other chemicals were purNorthern analysis chased from Sigma Chemical Co. (St. Louis, MO).
SC were plated (3 1 10 6 cells/T75 flask) in DMEM Antibodies and 10% FBS. After 2 days, the medium was removed, cells were rinsed twice in DMEM, and placed in G3 The anti-IGFBP-5 antibody (Upstate Biotechnology, Lake Placid, NY) used in this study is a polyclonal antisera media with 10 nM IGF-I in the presence or absence of 1 mM 8-bromo cAMP. After 24 hr, the culture media raised against immunoaffinity purified IGFBP-5 from the conditioned media of transfected CHO cells. This anti-was collected and the cells harvested for RNA using the guanidine isothiocyanate method (Chomczynski sera recognizes IGFBP-5 from human and rat. The cross-reactivities with other binding proteins are as fol-and Sacchi, 1987) . Total RNA (10 mg) was separated by size in formaldehyde-agarose gels and transferred to lows: IGFBP-1, õ0.5%; IGFBP-2, õ0.1%; IGFBP-3, õ0.1%; and IGFBP-4, less than 0.5%. The monoclonal nylon nytran membranes (Schleicher and Schuell, Keene, NH). Membranes were hybridized with 32 Panti-MBP antiserum (Boehringer Mannheim, Indianapolis, IN) recognizes residues 130 -137 of MBP from dCTP labeled (0.1 -10 1 10 8 cpm/mg) cDNA probes for rat IGFBP-5 and glyceraldehyde-3-phosphate dehydrohuman, chimpanzee, monkey, rabbit, bovine, and rat. The anti-P0 antiserum (P07) is a gift from Dr. Michael genase (GAPDH). Individual nytran membranes were hybridized by stripping and reprobing, as described Shy, Wayne State University, Detroit, MI and was originally developed by Dr. J. J. Archelos, Julius-Maximil-in the manufacturer's instructions (Schleicher and Schuell, Keene, NH). Relative optical density for each ians-Universitä t Wurzbü rg, Wurzbü rg, Germany. hybridization was determined densitometrically by avcDNA probes eraging several exposures in the linear range of the film. These values were expressed as a percentage of The rat IGFBP-5 cDNA was received from Dr. Shunichi Shimasaki, The Whittier Institute, La Jolla, CA. A the G3 control and were divided by the percentage of control values similarly obtained from GAPDH hybrid-300-bp rat IGFBP-5 cDNA, which encodes portions of the mature peptide, in pBluescript SK/ plasmid was ization (Cheng et al., 1996a) . generated by SacII and HindIII digestion. The cDNA Immunoblotting probes were purified with a Magic PCR Prep DNA Purification Kit from Promega (Madison, WI).
Protein (50 mg) of concentrated conditioned media (for IGFBP-5 immunoblots) or whole cell lysates (for Cell culture P0 immunoblots) were mixed at a 5:1 ratio with 101 SDS-sample buffer [100 mM Tris (pH 8), 10 mM EDTA, MT4H1 rat SC (SC) were provided kindly by Dr. Gihan Tennekoon, Children's Hospital of Philadelphia, 10% SDS, 100 mM dithiothreitol, 0.1% bromphenol blue, and 20% glycerol] and boiled for 3 -5 min. SamPhiladelphia, PA. These cells have been transfected with simian virus 40 (SV 40) large T antigen under the ples were separated by SDS-PAGE (12.5%) and electrophoretically transferred to nitrocellulose. Nitrocellucontrol of the metallothionine promoter (Tennekoon et al., 1987) . Expression of SV 40 large T antigen is sup-lose membranes were blocked with 5% nonfat dried milk in TBST [20 mM Tris, 0.16 M NaCl, and 0.10% pressed in the absence of zinc. Under these conditions, the cells behave like primary SCs expressing myelin Tween-20 (pH 7.4)]. The membranes were then incu- IGF-I enhanced the morphological changes. IGF-I (3 nM) treatment induced more cell aggregation (Fig. 1C) , bated for 2 hr with IGFBP-5 antiserum (1:1000) or anti-P0 (1:1000), in TBST / 5% milk, washed extensively whereas in the presence of 10 nM IGF-I, SCs assumed a slender bipolar configuration (tubular aggregates) with during a 30-min period with TBST, and then incubated for 1 hr with horseradish peroxidase-conjugated goat long processes. Cells also formed colonies with fascicles consisting of bundles of long cell processes radiating anti-rabbit antibody (1:7500, Santa Cruz Biotechnology) for IGFBP-5 or horse anti-mouse (1:1000, Santa out of each colony connecting to neighboring colonies (Fig. 1D ). Cruz Biotechnology) for P0 in TBST / 5% milk. After 40 min of extensive washing, nitrocellulose membranes
We also used the artificial basement membrane matrix, Matrigel matrix, to induce SC differentiation. SCs were incubated with enhanced chemiluminescence reagents (Amersham). Bound protein-antibody com-plated on Matrigel changed from a round, flattened morphology to a more bipolar or triangular configuraplexes were visualized by autoluminography on reflection-NEF film (Du Pont, Boston, MA). tion ( Fig. 2A) . SCs became elongated after the addition of 1 nM IGF-I (Fig. 2B ) whereas 3 nM IGF-I treatment RESULTS promoted the formation of cell fascicles and the exten-8-bromo cAMP and matrigel matrix induce SC sion of processes (Fig. 2C ). In the presence of 10 nM differentiation IGF-I, SCs formed similar structures to the cells treated with IGF-I and 8-bromo cAMP (Fig. 2D ). Thus, SCs express different phenotypes while undergoing differentiation (Yoshino et al., 1990 ; De Deyne et al., IGF-I affected SC morphology in at least two ways: by promoting cell clustering and by facilitating the exten-1994). We and others have observed that undifferentiated MT4H1 SCs have a flattened, round morphology sion of processes. Essentially, all SCs underwent the morphological changes depicted in Figs. 1 and 2. when cultured on plastic tissue culture dishes (Yoshino et al., 1990; De Deyne et al., 1994) . Upon differentiaDifferentiation not only induces changes in SC morphology but also activates the expression of myelin protion, SCs assume a distinct morphology, form polygonal and/or tubular aggregates and extend cellular pro-teins including P0 and myelin basic protein (MBP). To quantitate enhanced SC differentiation, we examined cesses (Yoshino et al., 1990; De Deyne et al., 1994) . We initially induced SC differentiation using two known P0 protein expression. After incubation in the presence or absence of 8-bromo cAMP and/or 10 nM IGF-I, SC SC differentiating factors: the cAMP analogue, 8-bromo cAMP and Matrigel matrix (Knight et al., 1993) . After whole cell lysates were collected and the extracted proteins were separated by SDS-PAGE followed by P0 imtreatment with 1 mM 8-bromo cAMP for 24 hr, SCs became smaller, polygonal cells and extended processes munoblotting procedures. P0 immunoblots demonstrated the presence of the 30 kD P0 protein (Fig. 3) . (Fig. 1A) . To test the effect of IGF-I on cAMP induced morphological changes, SCs were treated with increas-IGF-I (10 nM) enhanced P0 expression in comparison with untreated cells or cells treated with 1 mM 8-bromo ing concentrations of IGF-I in the presence of 1 mM 8-bromo cAMP. With the addition of 1 nM IGF-I, SCs cAMP alone (Fig. 3) . Maximal P0 protein expression was detected in cells treated for 2 days with both 8-began to group together and form aggregates, with long cellular processes (Fig. 1B) . Higher concentrations of bromo cAMP and 10 nM IGF-I (Fig. 3) . In parallel, JCP-454 / 8916$$0454 03-14-97 21:00:21 wlcpa W Liss: JCP Similar results were observed with cAMP treatment. SCs were incubated in defined media in the presence or absence of 1 mM 8-bromo cAMP and/or 10 nM IGF-I. Conditioned media were collected and concentrated, and proteins were separated by SDS-PAGE followed by IGFBP-5 immunoblotting. As in our previous experiments, we again observed that secreted IGFBP-5 was degraded in the absence but protected in the presence of IGF-I. 8-bromo cAMP (1 mM) significantly enhanced the expression of IGFBP-5 in the presence of 10 nM IGF-I (Fig. 5A) . We then examined the effects of two 2 and 6 with lanes 3 and 7, respectively) . Data are media in the presence of IGF-I (Fig. 5B) .
from one of three representative experiments.
We then asked if the effects of cAMP on IGFBP-5 protein expression was secondary to enhanced IGFBP-5 gene expression. Northern analysis was performed using RNA isolated from SCs cultured under the same conditions as the immunoblot experiments. As we have previously reported, IGF-I had no effect on IGFBP-5 gene expression (Cheng et al., 1996a) . However, addition of cAMP increased IGFBP-5 gene expression fivefold (Fig. 6 ).
DISCUSSION
The IGF family of ligands, receptors and binding proteins are essential for normal nervous system development (Carson et al., 1993; Liu et al., 1993) and instrumental in nervous system regeneration (Hansson, Matrigel-coated plates was higher than that from SCs grown on plastic uncoated plates. Data from one of three representative experiby differentiated SCs (Trapp et al., 1981 Trapp ments. and Owens and Bunge, 1990; Jessen and Mirsky, 1991 ). In the current study, we examined the role of IGF-I and IGFBP-5 in SC differentiation, as a first step in understanding the role of IGF family we observed low amounts of MBP immunoreactivity in untreated SCs. Treatment with 1 mM 8-bromo cAMP members in peripheral nervous system biology.
We have shown previously that IGF-I is a mitogen modestly enhanced the expression of MBP immunoreactive protein while the most intense immunofluores-for newly cultured SCs (Cheng et al., 1996a) . However, once SCs have begun to mature, we found that IGF-I cence was observed in cells treated with both cAMP and IGF-I (data not shown).
assumed a new role, that of a differentiating factor. After treatment with cAMP, IGF-I enhanced SC differ-IGFBP-5 expression is increased with SC entiation. Markers of SC differentiation included mordifferentiation phological changes and enhanced P0 and MBP expression. In parallel, De Deyne and colleagues have reSCs express IGFBP-5 (Cheng et al., 1996a); interestingly, IGFBP-5 is enhanced during differentiation in ported (1994) that SCs respond to cAMP by assuming a differentiated morphology characterized by reorganimultiple cell types and may play a role in the maintenance of a differentiated phenotype (Birnbaum and zation of microtubules. In our studies, IGF-I not only enhanced this process but also promoted cell clustering Wiren, 1994; Ewton and Florini, 1995; Rotwein et al., 1995) . In the current study, we examined the levels of and enhanced P0 and MBP expression. Interestingly, cell clustering is important for P0 expression (Knight IGFBP-5 produced by SCs upon differentiation. Conditioned media of SCs cultured on Matrigel-coated plates et al., 1993) . Consequently, we do not know whether the increase in P0 expression was due to a direct effect were collected and concentrated, and equal amounts of protein were separated by SDS-PAGE followed by of IGF-I signaling or secondary to the IGF-I coupled morphological changes. IGFBP-5 immunoblotting. As we have previously observed (Cheng et al., 1996a) , secreted IGFBP-5 was Similar phenomena were observed when SCs were grown on Matrigel. Matrigel contains many of the comdegraded in the absence but protected in the presence of IGF-I. Matrigel coating significantly enhanced the ponents of the SC basement membrane including laminin, type I and type IV collagen (McGarvey et al., 1984) . expression of IGFBP-5 in the presence of 10 nM IGF-I (Fig. 4) as well as the recent data of Doerr and Jones with breast cancer cells (Doerr and Jones, 1996) imply important cross-talk between IGF-I and integrin signaling cascades. We speculate that this link may be instrumental in IGF-I enhancement of SC differentiation. We recently reported that cultured SCs primarily express IGFBP-5 (Cheng et al., 1996a ). In the current study, we observed that treatment with either Matrigel or cAMP increased IGFBP-5 expression while mediating SC differentiation. Several other examples of IGFBP-5 enhancement with cellular differentiation imply this process may be an important component of normal tissue maturation. For example, enhanced expression of IGFBP-5 occurs during terminal muscle differentiation (James et al., 1993; Ewton and Florini, 1995; Rotwein et al., 1995; Duan et al., 1996) . Although IGFBP-5 is not detectable in dividing myoblasts (Ewton and Florini, 1995) , there is a marked increase in both IGFBP-5 mRNA and protein during myoblast differentiation (James et al., 1993; Ewton and Florini, 1995) , coincident with onset of myogenin gene expression (Rotwein et al., 1995) . Rotwein and colleagues recently found that the rapid upregulation of IGFBP-5 during muscle differentiation is mediated, in part, by a 156 nucleotide region of the IGFBP-5 promoter containing immunoblots were prepared using concentrated conditioned media from SCs grown on plastic plates { 10 nM IGF-I for 1 or 2 days. several potential binding sites for muscle cell-related A: In the absence of IGF-I, IGFBP-5 was degraded in SC conditioned transcription factors (Rotwein et al., 1995) . media (lanes 1, 2, 5, and 6). A 23-kD proteolytic fragment was visualWe also found that secreted IGFBP-5 was degraded ized after 2 days. In the presence of IGF-I, 1 mM 8-bromo cAMP in the absence but protected in the presence of IGF-I. a 23-kD degraded fragment. Several IGFBP-5 proteases have been isolated and characterized (Conover et al., 1993; Nam et al., 1994; Thrailkill et al., 1995) . A set of 52-to 72-kD IGFBP-5 the adhesion and differentiation of cultured SCs and Schwannoma cells by interacting with integrin recep-proteases isolated from osteoblast conditioned media are cation-dependent matrix metalloproteinases (Thrailkill tors (McGarvey et al., 1984; Baur et al., 1995) . In the current study, IGF-I enhanced Matrigel-coupled mor-et al., 1995) . Interestingly, these IGFBP-5 proteases are upregulated during osteoblast differentiation phological differentiation in SCs. Similar enhancement has been reported when SCs are cultured on Matrigel (Thrailkill et al., 1995) , suggesting IGFBP-5 proteases also are involved in IGF-I regulation of cellular differin 5% fetal bovine serum (Yoshino et al., 1990) . Our results suggest that IGF-I is one of the serum factors entiation.
The marked increase in IGFBP-5 expression during that contributes to these previous reports of serum enhancement of Matrigel-mediated SC differentiation.
SC differentiation led us to examine the effects of cAMP analogues on IGFBP-5 gene expression. As has been Like our observations with cAMP, we do not yet know the underlying mechanism of IGF-I enhancement of observed previously in human fibroblasts (Duan and Clemmons, 1995) , we found that treatment with cAMP Matrigel coupled SC differentiation. However, both our own work in neurons ; analogues increased IGFBP-5 gene expression. Recently, an AP-2 binding site was identified on the and a recent report in breast cancer cells (Doerr and Jones, 1996) suggest an interac-IGFBP-5 promoter, suggesting a direct interaction between the cAMP-response element and the IGFBP-5 tion between IGF-I receptor downstream signaling cascades and integrin-mediated intracellular signaling promoter (Duan and Clemmons, 1995) . Our results corroborate this concept and imply that previous reports pathways, known to induce SC differentiation. We have reported recently that IGF-I, as well as integrin bind-of increased IGFBP-5 gene expression by hormones (Camacho-Hubner et al., 1992) may actually be mediing, stimulates the activation of two proteins involved in neuronal adhesion, focal adhesion kinase and paxil-ated via cAMP. Similarly, our results of enhanced IGFBP-5 gene expression during SC differentiation lin . In parallel, Doerr and Jones (1996) have re-also parallel the upregulation of IGFBP-5 observed during myoblast (James et al., 1993; Ewton and Florini, ported that interaction of vitronectin with the avb5 integrin or collagen with the a2b1 integrin is required 1995; Rotwein et al., 1995; Duan et al., 1996) work (Cheng et al., 1996a) . This is in contrast to reports 48:189 -198. in aortic smooth muscle cells (Duan et al., 1996) , rat
Cheng, H-L., Randolph, A., Yee, D., Delafontaine, P., Tennekoon, G., FRTL-5 thyroid cells (Backeljauw et al., 1993) , and os- , 1992; Conover et al., 1995) , U2 osteosarcoma cells chemical localization of insulin-like growth factor binding protein- (Conover et al., 1993) , and breast carcinoma cells 5 in the developing rat nervous system. Dev. Brain Res., 92:211 - (Shemer et al., 1993) . These differences emphasize that 218. Chomczynski, P., and Sacchi, N. (1987) Single-step method of RNA stimulation of IGFBP-5 gene expression by IGF-I is a isolation by acid guanidinium thiocyanate-phenol-chloroform excell-type specific event and discrepancies in regulation traction. Anal. Biochem., may reflect both cell-specific as well as species-specific Clemmons, D.R., Nam, T.J., Busby, W.H., and Parker, A. (1994) 
